Janux Therapeutics, Inc.

NASDAQ:JANX

29.25 (USD) • At close March 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -68.994-58.293-63.059-32.672-6.784-4.004
Depreciation & Amortization 2.061.9550.8410.1130.0130.006
Deferred Income Tax 000000
Stock Based Compensation 33.0220.00517.2036.910.0720.006
Change In Working Capital 0.685-6.5544.2768.8420.389-0.069
Accounts Receivables 0008-80
Inventory 0000.8310.3750
Accounts Payables 1.5840.277-0.2942.1390.0140.004
Other Working Capital -0.899-6.8314.57-2.1288-0.073
Other Non Cash Items -10.585-7.688-2.183-0.1691.9410.233
Operating Cash Flow -43.814-50.575-42.922-16.976-4.369-3.828
Investing Activities:
Investments In Property Plant And Equipment -0.359-1.85-6.445-1.48200
Acquisitions Net 00-64.711339.48100
Purchases Of Investments -470.577-317.344-294.389-473.62600
Sales Maturities Of Investments 212.915278359.1134.14500
Other Investing Activites 0064.711-339.48100
Investing Cash Flow -258.021-41.19458.266-340.96300
Financing Activities:
Debt Repayment 00002.54
Common Stock Issued 698.26756.530.5204.1679.0240
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 14.9683.0180.5182.35717.9780
Financing Cash Flow 713.23559.5480.5386.52411.5244
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 411.4-32.22115.84428.5857.1550.172
Cash At End Of Period 431.42120.02152.24236.3987.8130.658